BOEHRINGER INGELHEIM PHARMACEUTICALS INC has a total of 49 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia, Saudi Arabia and African Regional Industrial Property Organization. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are REDDY RESEARCH FOUNDATION, BILODEAU MARK T and CEREP SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 31 | |
#2 | Saudi Arabia | 5 | |
#3 | African Regional Industrial Property Organization | 3 | |
#4 | Chile | 2 | |
#5 | Montenegro | 2 | |
#6 | Ecuador | 1 | |
#7 | Japan | 1 | |
#8 | Malaysia | 1 | |
#9 | Norway | 1 | |
#10 | Serbia | 1 | |
#11 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Chemical engineering | |
#7 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Bekkali Younes | 7 |
#2 | Kuzmich Daniel | 6 |
#3 | Zindell Renee | 6 |
#4 | Takahashi Hidenori | 6 |
#5 | Razavi Hossein | 5 |
#6 | Hickey Eugene R | 5 |
#7 | Betageri Rajashekhar | 5 |
#8 | Wang Ji | 5 |
#9 | Cardozo Mario G | 5 |
#10 | Kirrane Thomas M | 5 |
Publication | Filing date | Title |
---|---|---|
AU2005223738A1 | 3-'4-heterocyclyl -1,2,3,-triazol-1-yl-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases | |
MY163491A | Clucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
AU2003230700A1 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
AU2003218342A1 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
AU2002334935B2 | Powder processing with pressurized gaseous fluids | |
AU1617901A | Urea derivatives as anti-inflammatory agents |